Indinavir

Indinavir
Indinavir
Indinavir

Indinavir

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 98%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

[SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N')[ETHANEDIOATA(2-)-O,O']PLATINUM OXALIPLATIN trans-l-diaminocyclohexane oxalatoplatinum

Quick Details

  • Appearance:powder
  • Application:A antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA
  • PackAge:depended
  • ProductionCapacity:200|Kilogram|Month
  • Storage:Store in dry, dark and ventilated place
  • Transportation:by air or by sea

Superiority:

 


Preview
CBNumber: CB1217931
Chemical Name: Oxaliplatin
Molecular Formula: C8H14N2O4Pt
Formula Weight: 397.29
CAS No.: 61825-94-3

 

Details:

Oxaliplatin Basic information
Treatment of colorectal cancer Adverse reactions and side effects Chemical Properties Application production method
Product Name: Oxaliplatin
Synonyms: [SP-4-2-(1R-TRANS)]-(1,2-CYCLOHEXANEDIAMINE-N,N')[ETHANEDIOATA(2-)-O,O']PLATINUM;OXALIPLATIN;trans-l-diaminocyclohexane oxalatoplatinum;(1,2-cyclohexanediamine-n,n’)(ethanedioato(2-)-o,o’)-platinu(sp-4-2-(1r-tr;1-ohp;oxalato(1r,2r-cyclohexanediammine)platinum(ii);oxalatoplatin;oxalatoplatinum
CAS: 61825-94-3
MF: C8H14N2O4Pt
MW: 397.29
EINECS: 274-613-9
Product Categories: Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;Antineoplastic;Intermediates & Fine Chemicals;Pharmaceuticals;APIs;Amines;Heterocycles;chemical reaction,pharm,electronic,materials;PRAXILENE;Inhibitors
Mol File: 61825-94-3.mol
Oxaliplatin Structure
 
Oxaliplatin Chemical Properties
storage temp.  Store at +4°C
form  solid
Stability: Stable. Store cool. Incompatible with oxidizing agents.
 
Safety Information
Hazard Codes  Xn,Xi
Risk Statements  36/37/38-40-42/43
Safety Statements  26-36
RIDADR  2811
WGK Germany  3
RTECS  TP2275850
HazardClass  6.1(a)
PackingGroup  II

 

Oxaliplatin Usage And Synthesis
Treatment of colorectal cancer Oxaliplatin belongs to platinum derivatives for the treatment of patients with colorectal cancer metastasis after the failure of the clinical treatment through fluorouracil , it can be used alone or in combination with the use of fluorouracil, it is the third generation of new class of anti-tumor platinum compounds for colorectal cancer after cisplatin and carboplatin , and so far it has been the only envelope platinum drug which has a significant activity. The Principle is by producing alkylation conjugate to act on DNA, to form crosslinks within the chain and between the chain which inhibit DNA synthesis and replication.at the same time, it can inhibit the hyperplasia of ovarian cancer and melanoma cell lines. 
August 2002, the US Food and Drug Administration (FDA) approved the Sanofi Saint raborg company's anticancer drug oxaliplatin (, Eloxatin) for the second-line treatment of metastatic colon cancer.
January 2004, the US Food and Drug Administration (FDA) formally approved the injection of oxaliplatin (Eloxatin) and 5-fluorouracil (5FU) and leucovorin (LV) Joint (FOLFOX program) for the first-line treatment of advanced colorectal cancer.
The domestic market is currently dominated by Sanofi - Aventis (Eloxatin); Jiangsu Hengrui Medicine Co., Ltd. (Oxaliplatin); Jiangsu Nanjing Pharmaceutical (Austrian platinum) three manufacturers monopoly, which occupy more than 85% of the domestic market share .
Adverse reactions and side effects 1, the hematopoietic system: oxaliplatin has some hematologic toxicity. When administered alone,it can cause the following adverse reactions: anemia, leukopenia, neutropenia, thrombocytopenia, sometimes up to grade 3 or 4. When in combination with 5-fluorouracil , neutropenia and thrombocytopenia diseases’ hematological toxicity increases . 
2, the digestive system:When administered alone, it can cause nausea, vomiting, diarrhea. These symptoms sometimes are very serious. When in combination with 5-fluorouracil, these side effects are increased significantly. It is Recommended to give preventive and / or therapeutic anti-emetic medication . 
3,the nervous system: peripheral neuritis, characterized by peripheral sensory neuropathy. Sometimes there are accompanied around the mouth, upper respiratory tract and upper digestive tract spasms and sensory disorders.
The above information is edited by the Chemicalbook of Tian Ye.
Chemical Properties Triangular flaky colorless crystals. The water solubility is 7.9mg / ml.
Application For the treatment of colorectal cancer.
production method 5g of trans-cyclohexanediamine and 18g K2 (PtCl4) aqueous solution react at room temperature for 12h, to give 12g intermediate product (I). 6: 8g of silver nitrate is added to 3g Compound (I) aqueous solution , the mixture is stirred for 2 ~ 3h under the dark, then add 4.8g oxalic acid dipotassium salt, react for 8h at room temperature , oxaliplatin is obtained .
Chemical Properties White Crystalline Solid
Usage Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.
Usage vasodilator
Usage A antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA
Biological Activity Antitumor agent that forms platinum-DNA adducts. Causes intra- and interstrand DNA crosslinks blocking DNA replication and transcription. Displays higher cytotoxicity and lower nephrotoxicity than analog cisplatin (cis-Diaminodichloroplatinum ) and shows antitumor activity in cell lines with acquired cisplatin resistance.

 

View All
Visit Store

You Might Also Like

Related Searches

Contact Supplier

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View